Inhibikase Therapeutics, Inc. Common Stock (IKT)

$2.49 -1.39% (delayed · 2026-09-04)

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Research Inhibikase Therapeutics, Inc. Common Stock (IKT): delayed quotes, charts, headlines, earnings calendar events, and SEC 10-K / 10-Q / 8-K filings on tkrhub.

Inhibikase Therapeutics, Inc. Common Stock (IKT) $2.49 -1.39% — delayed US quotes, charts, news & SEC filings on tkrhub. BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUB

What you can review

• Delayed session quotes and daily charts
• Related headlines and press context
• Earnings / catalyst calendar windows
• SEC 10-K, 10-Q, and 8-K filings in-app

tkrhub is a US equity research desk — not a broker. Quotes are typically delayed ~15 minutes.